PL3160923T3 - Nowy preparat i sposób syntezy - Google Patents
Nowy preparat i sposób syntezyInfo
- Publication number
- PL3160923T3 PL3160923T3 PL15732267T PL15732267T PL3160923T3 PL 3160923 T3 PL3160923 T3 PL 3160923T3 PL 15732267 T PL15732267 T PL 15732267T PL 15732267 T PL15732267 T PL 15732267T PL 3160923 T3 PL3160923 T3 PL 3160923T3
- Authority
- PL
- Poland
- Prior art keywords
- synthesis
- novel formulation
- formulation
- novel
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
- C07C227/20—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1411569.5A GB201411569D0 (en) | 2014-06-30 | 2014-06-30 | Novel formulation and method of synthesis |
| EP15732267.8A EP3160923B1 (en) | 2014-06-30 | 2015-06-30 | Novel formulation and method of synthesis |
| PCT/EP2015/064796 WO2016001199A1 (en) | 2014-06-30 | 2015-06-30 | Novel formulation and method of synthesis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3160923T3 true PL3160923T3 (pl) | 2019-06-28 |
Family
ID=51410328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15732267T PL3160923T3 (pl) | 2014-06-30 | 2015-06-30 | Nowy preparat i sposób syntezy |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11077216B2 (enExample) |
| EP (2) | EP3431460B1 (enExample) |
| JP (3) | JP6997519B2 (enExample) |
| KR (1) | KR102381616B1 (enExample) |
| CN (1) | CN106458785B (enExample) |
| AU (1) | AU2015283054B2 (enExample) |
| BR (1) | BR112016030350B1 (enExample) |
| CA (1) | CA2953641C (enExample) |
| DK (1) | DK3431460T3 (enExample) |
| ES (1) | ES2710073T3 (enExample) |
| GB (1) | GB201411569D0 (enExample) |
| IL (1) | IL249348A0 (enExample) |
| PL (1) | PL3160923T3 (enExample) |
| PT (1) | PT3160923T (enExample) |
| RU (1) | RU2016147507A (enExample) |
| SG (1) | SG11201610883QA (enExample) |
| TR (1) | TR201901460T4 (enExample) |
| WO (1) | WO2016001199A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220001034A1 (en) * | 2014-06-30 | 2022-01-06 | Ge Healthcare Limited | Novel formulation and method of synthesis |
| US12181452B2 (en) | 2017-09-18 | 2024-12-31 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| US12180581B2 (en) | 2017-09-18 | 2024-12-31 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| US11709156B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved analytical analysis |
| US11709155B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| GB201805253D0 (en) | 2018-03-29 | 2018-05-16 | Ge Healthcare Ltd Ip | Solid phase extraction |
| GB201915206D0 (en) | 2019-10-21 | 2019-12-04 | Ge Healthcare Ltd | Use of cyclodextrins as a radiostabilizer |
| US11918936B2 (en) | 2020-01-17 | 2024-03-05 | Waters Technologies Corporation | Performance and dynamic range for oligonucleotide bioanalysis through reduction of non specific binding |
| WO2022064447A1 (en) | 2020-09-24 | 2022-03-31 | Waters Technologies Corporation | Chromatographic hardware improvements for the separation of reactive molecules |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1356827A1 (en) | 2002-04-24 | 2003-10-29 | Mallinckrodt Inc. | Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution |
| US7993626B2 (en) | 2007-01-11 | 2011-08-09 | Immunomedics, Inc. | Methods and compositions for F-18 labeling of proteins, peptides and other molecules |
| CN100418585C (zh) | 2003-07-24 | 2008-09-17 | 伯拉考成像股份公司 | 稳定的放射性药物组合物及制备方法 |
| GB0422004D0 (en) | 2004-10-05 | 2004-11-03 | Amersham Plc | Method of deprotection |
| CA2612187C (en) | 2005-06-23 | 2013-05-07 | Emory University | Stereoselective synthesis of amino acid analogs for tumor imaging |
| RU2428415C2 (ru) | 2005-11-29 | 2011-09-10 | Нихон Меди-Физикс Ко., Лтд. | Соединение-предшественник органического соединения, меченного радиоактивным галогеном |
| US7897811B2 (en) | 2006-05-11 | 2011-03-01 | Nihon Medi-Physics Co., Ltd. | Process for production of radioactive fluorine-labeled organic compound |
| US8790620B2 (en) | 2006-12-21 | 2014-07-29 | Nihon Medi-Physics Co., Ltd. | Radioactive diagnostic imaging agent |
| EP2119458B9 (en) | 2007-02-13 | 2013-08-21 | Nihon Medi-Physics Co., Ltd. | Method for production of radiation diagnostic imaging agent |
| KR20130132892A (ko) | 2010-12-29 | 2013-12-05 | 지이 헬쓰케어 리미티드 | 용리제 용액 |
| GB201117785D0 (en) | 2011-10-14 | 2011-11-30 | Ge Healthcare Ltd | Improved radiosynthesis method |
| JP6446268B2 (ja) * | 2011-12-21 | 2018-12-26 | ジーイー・ヘルスケア・リミテッド | クエン酸緩衝液中の１８ｆ−フルシクロビン組成物 |
| GB201205703D0 (en) | 2012-03-30 | 2012-05-16 | Ge Healthcare Ltd | Synthon composition |
| GB201214220D0 (en) | 2012-08-09 | 2012-09-19 | Ge Healthcare Ltd | Radiosynthesis |
-
2014
- 2014-06-30 GB GBGB1411569.5A patent/GB201411569D0/en not_active Ceased
-
2015
- 2015-06-30 EP EP18187551.9A patent/EP3431460B1/en active Active
- 2015-06-30 TR TR2019/01460T patent/TR201901460T4/tr unknown
- 2015-06-30 BR BR112016030350-4A patent/BR112016030350B1/pt active IP Right Grant
- 2015-06-30 DK DK18187551.9T patent/DK3431460T3/da active
- 2015-06-30 PT PT15732267T patent/PT3160923T/pt unknown
- 2015-06-30 JP JP2016573925A patent/JP6997519B2/ja active Active
- 2015-06-30 AU AU2015283054A patent/AU2015283054B2/en active Active
- 2015-06-30 ES ES15732267T patent/ES2710073T3/es active Active
- 2015-06-30 PL PL15732267T patent/PL3160923T3/pl unknown
- 2015-06-30 CN CN201580035646.6A patent/CN106458785B/zh active Active
- 2015-06-30 RU RU2016147507A patent/RU2016147507A/ru unknown
- 2015-06-30 EP EP15732267.8A patent/EP3160923B1/en active Active
- 2015-06-30 SG SG11201610883QA patent/SG11201610883QA/en unknown
- 2015-06-30 CA CA2953641A patent/CA2953641C/en active Active
- 2015-06-30 WO PCT/EP2015/064796 patent/WO2016001199A1/en not_active Ceased
- 2015-06-30 KR KR1020167036497A patent/KR102381616B1/ko active Active
- 2015-06-30 US US15/318,599 patent/US11077216B2/en active Active
-
2016
- 2016-12-01 IL IL249348A patent/IL249348A0/en active IP Right Grant
-
2020
- 2020-07-02 JP JP2020114659A patent/JP2020172518A/ja active Pending
-
2022
- 2022-06-13 JP JP2022095283A patent/JP7657759B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3065470T3 (en) | Novel micro-dystrophins and related methods of use | |
| IL250415B (en) | Antibodies against pd-l and methods of using them | |
| IL250744A0 (en) | A method for preparing flavociclib and its pharmaceutical preparations | |
| HUE061672T2 (hu) | Glikán-interakcióban lévõ vegyületek és felhasználási módszerek | |
| HUE056172T2 (hu) | Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra | |
| PT3089971T (pt) | Compostos e métodos de utilização | |
| PT3102555T (pt) | Composições de compostos e seus usos | |
| IL249348A0 (en) | A new preparation and method for synthesis | |
| EP3179994A4 (en) | Modified mito-metformin compounds and methods of synthesis and use thereof | |
| SG11201609066QA (en) | Methods of producing tissue-mimetic constructs and uses thereof | |
| PL3113774T3 (pl) | Kompozycje grapiprantu i sposoby ich zastosowania | |
| SG11201605915WA (en) | Furo-3-carboxamide derivatives and methods of use | |
| SG11201803284YA (en) | Novel method of use and compositions | |
| HUE044559T2 (hu) | Lerakódást gátló készítmények és alkalmazási eljárásaik | |
| ZA201606450B (en) | Compounds and their methods of use | |
| ZA201701976B (en) | Synthesis of ent-progesterone and intermediates thereof | |
| HUE057149T2 (hu) | Mikromolekula vegyület, eljárás szintézisére és alkalmazására | |
| IL249463A0 (en) | Production method for (s)-2-acetyloxypropionic acid and their derivatives | |
| GB201408171D0 (en) | Formulation and method of manufacture | |
| GB201403697D0 (en) | Compounds and methods of use | |
| GB201416951D0 (en) | Method of synthesis | |
| GB201408738D0 (en) | Components and methods for formulation of components | |
| GB201416797D0 (en) | Contianer and method of use thereof | |
| GB201419990D0 (en) | Hprseshoe and method of manufacture | |
| SG11201605485QA (en) | Synthesis method of 9-allylcamptothecin derivatives |